Clinical Trials Browser

INDUSTRY × Interventional × plitidepsin × Clear all

NCT03117361 2020-12-02

Trial of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Multiple Myeloma Patients Double Refractory to Bortezomib and Lenalidomide

Phase 2 Terminated

10 enrolled 37 charts

Multiple Myeloma

NCT00780975 2020-11-24

A Study of Aplidin ( Plitidepsin) in Subjects With Advanced Prostate Cancer

Phase 2 Terminated

8 enrolled 9 charts

Neoplasms, Prostatic Neoplasms

NCT01102426 2020-11-10

ADMYRE

Phase 3 Completed

255 enrolled 32 charts

Multiple Myeloma

NCT03070964 2020-10-14

A Study of Plitidepsin in Patients With Relapsed or Refractory Angioimmunoblastic T-cell Lymphoma

Phase 2 Terminated

14 enrolled 21 charts

Lymphoma

NCT02100657 2020-10-12

Study of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Patients With Multiple Myeloma

Phase 1 Completed

39 enrolled 30 charts

Multiple Myeloma

NCT00780143 2018-11-09

Clinical Study of Plitidepsin (Aplidin®) in Combination With Cytarabine in Patients With Relapsed/Refractory Leukemia

Phase 1/2 Terminated

3 enrolled 6 charts

Other hematologic neoplasm

Leukemia, Neoplasms

NCT00884286 2018-04-25

Multicenter Trial to Treat Patients With Relapsed/Refractory Aggressive Non Hodgkin Lymphoma

Phase 2 Completed

67 enrolled 14 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma

NCT00788099 2011-06-07

Study of Plitidepsin in Combination With Sorafenib or Gemcitabine in Patients With Advanced Solid Tumors or Lymphomas

Phase 1 Completed

Lymphoma, Neoplasms

NCT00229203 2009-12-24

A Study of Aplidin (Plitidepsin) 3 h iv in Subjects With Relapsing or Refractory Multiple Myeloma

Phase 2 Completed

51 enrolled 10 charts

Multiple Myeloma, Neoplasms, Plasma Cell